Wockhardt declined 6.31% to Rs 601.65 at 12:05 IST on BSE, with the stock extending recent fall.
Meanwhile, the BSE Sensex was down 155.21 points, or 0.63%, to 24,400.88
On BSE, so far 3.35 lakh shares were traded in the counter, compared with an average volume of 5.35 lakh shares in the past one quarter.
The stock hit a high of Rs 647.90 and a low of Rs 597 so far during the day. The stock hit a 52-week high of Rs 1,304.20 on 28 May 2013. The stock hit a 52-week low of Rs 336.60 on 16 December 2013.
The stock had underperformed the market over the past one month till 28 May 2014, falling 11.03% compared with 8.50% rise in the Sensex. The scrip, however, outperformed the market in past one quarter, gaining 45.25% as against Sensex's 16.27% rise.
The mid-cap company has an equity capital of Rs 54.88 crore. Face value per share is Rs 5.
Shares of Wockhardt have been on a downward spiral recently, with the stock declining 17.74% in six trading days from a recent low of Rs 731.40 on 21 May 2014. The fall caught momentum after the company reported weak result for Q4 and full year ended 31 March 2014 after market hours on Monday, 26 May 2014.
Wockhardt's consolidated net profit fell 77.8% to Rs 74.45 crore on 30% decline in total income to Rs 1047.67 crore in Q4 March 2014 over Q4 March 2013.
On a consolidated basis, Wockhardt's net profit fell 47.3% to Rs 840.71 crore on 14.3% decline in total income to Rs 4918.59 crore in the year ended March 2014 over the year ended March 2013.
Wockhardt is a high-technology intensive global pharmaceutical and biotechnology company with multi-disciplinary and innovative R&D programmes. It has three research centres globally and manufacturing facilities across India, USA, UK and Ireland. The company has a significant presence in USA, Europe and India.
Powered by Capital Market - Live News
